Trial Profile
Multiple escalating dose trial of anivamersen-pegnivacogin [REG2] in adult volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2014
Price :
$35
*
At a glance
- Drugs Anivamersen-pegnivacogin (Primary)
- Indications Venous thrombosis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Regado Biosciences
- 16 Mar 2010 New trial record